Administration Of Hepatitis A Vaccine To A Military Population By Needle And
Military personnel are an important target population for hepatitis A immunization. Soldiers are often given vaccines by jet injector and may be required to receive multiple vaccines at one time. Formalin-inactivated hepatitis A vaccine containing 360 ELISA units of antigen was evaluated at Fort Cam...
Saved in:
Published in | The Journal of infectious diseases Vol. 171; no. Supplement-1; pp. S53 - S60 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
The University of Chicago Press
01.03.1995
|
Online Access | Get full text |
Cover
Loading…
Summary: | Military personnel are an important target population for hepatitis A immunization. Soldiers are often given vaccines by jet injector and may be required to receive multiple vaccines at one time. Formalin-inactivated hepatitis A vaccine containing 360 ELISA units of antigen was evaluated at Fort Campbell. Volunteers received vaccine at 0, 1, and 6 months as follows: group 1, hepatitis A vaccine by needle; group 2, hepatitis A vaccine by jet injector; group 3, hepatitis B vaccine by needle; and group 4, both hepatitis vaccines by needle in separate arms. Immune response and reactogenicity were evaluated. After two doses, recipients of vaccine administered by jet injector had a higher prevalence of antibody than those who received vaccine by needle (93% vs. 79%). By the 8th month, the vaccine was 100% immunogenic by either route or with hepatitis B vaccine. No interaction between hepatitis A and B vaccines was detected. |
---|---|
Bibliography: | Reprints or correspondence: Dr. Charles H. Hoke, Jr., Dept. of Virus Diseases, Walter Reed Army Institute of Research, Washington, DC 203075100. Present affiliations: Ogden Biosciences, Rockville. Maryland (R.R.); Walter Reed Army Medical Center, Washington, DC (M.H,S.); US Army Medical Research and Material Development Command (Provisional), Fort Detrick (W.H.B.); Colorado Springs. Colorado (A.B.); Louisiana State University Medical School, New Orleans (J.H.); Johns Hopkins University. Baltimore (L. E.). istex:2CDC50C9E3897AE7D7B41C4328022C3A615B6E98 ark:/67375/HXZ-5RVXB4K8-V |
ISSN: | 0022-1899 1537-6613 |
DOI: | 10.1093/infdis/171.Supplement_1.S53 |